The prognostic value of B-type natriuretic peptide in patients with acute coronary syndromes.

No abstract is available for this paper.

• Publication year

  2001

• Venue

  New England Journal of Medicine

• Publication date

  2001-10-04

• Fields of study

  Medicine

• Identifiers
  DOI 10.1056/NEJMOA011053PMID 11586953
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• A rapid bedside test for B-type peptide predicts treatment outcomes in patients admitted for decompensated heart failure: a pilot study.

  2001cited by this paper
• Comparison of early invasive and conservative strategies in patients with unstable coronary syndromes treated with the glycoprotein IIb/IIIa inhibitor tirofiban.

  2001cited by this paper
• Utility of B-type natriuretic peptide in the diagnosis of congestive heart failure in an urgent-care setting.

  2001cited by this paper
• Oral glycoprotein IIb/IIIa inhibition with orbofiban in patients with unstable coronary syndromes (OPUS-TIMI 16) trial.

  2000cited by this paper
• Cardiac troponin I for stratification of early outcomes and the efficacy of enoxaparin in unstable angina: a TIMI-11B substudy.

  2000cited by this paper
• Brain natriuretic peptide increases acutely and much more prominently than atrial natriuretic peptide during coronary angioplasty

  2000cited by this paper
• Plasma N terminal pro-brain natriuretic peptide and cardiotrophin 1 are raised in unstable angina

  2000cited by this paper
• Brain natriuretic peptide increases acutely and much more prominently than atrial natriuretic peptide during coronary angioplasty

  2000cited by this paper
• Gene Expression of Brain Natriuretic Peptide in Isolated Atrial and Ventricular Human Myocardium: Influence of Angiotensin II and Diastolic Fiber Length

  2000cited by this paper
• Profile of plasma N-terminal proBNP following acute myocardial infarction; correlation with left ventricular systolic dysfunction.

  2000cited by this paper
• Transient increase in plasma brain (b‐type) natriuretic peptide after percutaneous transluminal coronary angioplasty

  2000cited by this paper
• Enoxaparin prevents death and cardiac ischemic events in unstable angina/non-Q-wave myocardial infarction. Results of the thrombolysis in myocardial infarction (TIMI) 11B trial.

  1999cited by this paper
• Neuroendocrine prediction of left ventricular function and heart failure after acute myocardial infarction

  1999cited by this paper
• Benefit of abciximab in patients with refractory unstable angina in relation to serum troponin T levels. c7E3 Fab Antiplatelet Therapy in Unstable Refractory Angina (CAPTURE) Study Investigators.

  1999cited by this paper
• Plasma brain natriuretic peptide is a biochemical marker for the prediction of progressive ventricular remodeling after acute myocardial infarction.

  1998cited by this paper
• Plasma N-terminal pro-brain natriuretic peptide and adrenomedullin: new neurohormonal predictors of left ventricular function and prognosis after myocardial infarction.

  1998cited by this paper
• Natriuretic peptides: physiology, therapeutic potential, and risk stratification in ischemic heart disease.

  1998cited by this paper
• Inflammation, pravastatin, and the risk of coronary events after myocardial infarction in patients with average cholesterol levels. Cholesterol and Recurrent Events (CARE) Investigators.

  1998cited by this paper
• Diagnostic value of B-type natriuretic peptide concentrations in patients with acute myocardial infarction.

  1996cited by this paper
• Plasma brain natriuretic peptide concentrations predict survival after acute myocardial infarction.

  1996cited by this paper
• Plasma cardiac natriuretic peptide determination as a screening test for the detection of patients with mild left ventricular impairment.

  1996cited by this paper
• Increased plasma levels of B-type natriuretic peptide in patients with unstable angina.

  1996cited by this paper
• Plasma brain natriuretic peptide as an indicator of left ventricular systolic function and long-term survival after acute myocardial infarction. Comparison with plasma atrial natriuretic peptide and N-terminal proatrial natriuretic peptide.

  1996cited by this paper
• Rapid ventricular induction of brain natriuretic peptide gene expression in experimental acute myocardial infarction.

  1995cited by this paper
• Increased secretion of atrial and brain natriuretic peptides during acute myocardial ischaemia induced by dynamic exercise in patients with angina pectoris.

  1995cited by this paper
• Relationship between plasma level of brain natriuretic peptide and myocardial infarct size.

  1994cited by this paper
• Localization and Mechanism of Secretion of B‐Type Natriuretic Peptide in Comparison With Those of A‐Type Natriuretic Peptide in Normal Subjects and Patients With Heart Failure

  1994cited by this paper
• Plasma brain natriuretic peptide as an indicator for angiotensin-converting-enzyme inhibition after myocardial infarction.

  1993cited by this paper
• Increased Plasma Levels of Brain Natriuretic Peptide in Patients With Acute Myocardial Infarction

  1993cited by this paper
• Different Secretion Patterns of Atrial Natriuretic Peptide and Brain Natriuretic Peptide in Patients With Congestive Heart Failure

  1993cited by this paper
• Serial changes in atrial and brain natriuretic peptides in patients with acute myocardial infarction treated with early coronary angioplasty.

  1993cited by this paper

• Prognostic value of N-terminal pro-B-type natriuretic peptide and C reactive protein testing in patients with acute ST-segment elevation myocardial infarction

  2026cites this paper
• Association Between Serum Lipid-Bilirubin Ratio and Clinical Prognosis Among Patients Undergoing Percutaneous Coronary Intervention After Coronary Artery Bypass Grafting

  2025cites this paper
• Growth Differentiation Factor‐15 is Associated With Acute Myocardial Infarction and Death at 30 and 90 Days in Emergency Department Patients With Suspected Acute Coronary Syndrome

  2025cites this paper
• Urine and Serum Biomarkers of Cardiovascular Status and Early Vascular Ageing in Children and Adults

  2025cites this paper
• Use of NT‐proBNP for the screening, diagnosis and risk‐stratification of left ventricular dysfunction

  2025cites this paper
• Decoding Survival in Elderly Acute Myocardial Infarction: The Prognostic Interplay of B-Type Natriuretic Peptide, Ejection Fraction, and Renal Function – An Observational Study

  2025cites this paper
• Biomarkers for cardiovascular–kidney metabolic syndrome: Clinical utility in diagnosis, screening, and treatment

  2025cites this paper
• Enhancing risk stratification post-myocardial infarction: prognostic value of NT-proBNP and fQRS.

  2025cites this paper
• Associations of N-Terminal Pro-Brain Natriuretic Peptide with Incident Chronic Kidney Disease and All-Cause Mortality in Patients with No History of Heart Failure and Diabetes.

  2025cites this paper
• Statistical approaches for systematically missing covariates in individual participant data meta-analysis: insights and applications using 5 large cardiovascular trials.

  2025cites this paper
• Risk Stratification of Acute Chest Pain in Patients With High‐Sensitivity Troponin T Below the 99th Percentile: A Long‐Term Cohort Study Assessing the Incremental Value of Necrosis and Non‐necrosis Biomarkers to Clinical Risk Scores

  2025cites this paper
• Cardiac biomarkers and CT coronary angiography for the assessment of coronary heart disease.

  2024cites this paper
• Impact of age on the predictive value of NT-proBNP in patients with diabetes mellitus stabilised after an acute coronary syndrome.

  2024cites this paper
• Current and Prospective Biochemical Markers for the Identification of Acute Coronary Syndrome-A Review

  2024cites this paper
• Novel Biomarkers and Their Role in the Diagnosis and Prognosis of Acute Coronary Syndrome

  2023cites this paper
• Machine learning-based models to predict one-year mortality among Chinese older patients with coronary artery disease combined with impaired glucose tolerance or diabetes mellitus

  2023cites this paper
• A New Risk Model Based on the Machine Learning Approach for Prediction of Mortality in the Respiratory Intensive Care Unit.

  2023cites this paper
• Fifteenth Annual Scientific Meeting-Institute Of Cardiovascular Science And Fifteenth Annual Scientific Meeting-Institute Of Cardiovascular Science And Medicine Medicine

  2023cites this paper
• NT-proBNP in patients presenting with myocardial infarction and non-obstructive coronary arteries without left ventricular systolic dysfunction

  2023cites this paper
• Aberrant expression of NPPB through YAP1 and TAZ activation in mesothelioma with Hippo pathway gene alterations

  2023cites this paper
• The role of admission platelet count and B-type natriuretic peptide in predicting in hospital morbidity in ST-elevation myocardial infarction patients

  2023cites this paper
• The impact of COVID-19 on BNP, NT-proBNP and ANP in heart failure.

  2023cites this paper
• Diagnostic accuracy of plasma brain natriuretic peptide for evaluation of dyspnea NYHA-III and NYHA-IV in emergency department of tertiary care hospital

  2023cites this paper
• Deep learning-based NT-proBNP prediction from the ECG for risk assessment in the community

  2023cites this paper
• Mortality in Patients with Acute Coronary Syndrome—A Prospective 5-Year Follow-Up Study

  2023cites this paper
• Bilirubin and its oxidative metabolite biopyrrins in patients with acute myocardial infarction

  2023cites this paper
• Prognostic Importance of NT-proBNP (N-Terminal Pro-B-Type Natriuretic Peptide) Following High-Risk Myocardial Infarction in the PARADISE-MI Trial

  2023cites this paper
• Prognostic modelling of clinical outcomes after first-time acute coronary syndrome in New Zealand

  2023cites this paper
• Prognostic Value of N-terminal Pro-brain Natriuretic Peptide in Risk Prognostic Value of N-terminal Pro-brain Natriuretic Peptide in Risk Stratification of Non-ST Elevation Myocardial Infarction / Unstable Angina Stratification of Non-ST Elevation Myocardial Infarction / Unstable Angina

  2023cites this paper
• Circulating Biomarkers for Monitoring Chemotherapy-Induced Cardiotoxicity in Children

  2023cites this paper
• Clinical Profile of Patients with Hypertensive Emergency Referred to a Tertiary Hospital in the Western Cape Province of South Africa.

  2023cites this paper
• Nt-proBNP in Pediatric Cardiac Surgery: A Correlation Study with the Postoperative Course and Morbidity

  2023cites this paper
• The Role of Cardiac Biomarkers in the Diagnosis of Hypertensive Emergency

  2023cites this paper
• Use of Preoperative Natriuretic Peptide in Predicting Mortality After Coronary Artery Bypass Grafting: A Systematic Review and Meta-analysis.

  2023cites this paper
• Higher NT-proBNP levels are related to poor functional outcome and pneumonia in acute intracerebral hemorrhage patients.

  2022cites this paper
• Synergistic action of organophosphates and COVID-19 on inflammation, oxidative stress, and renin-angiotensin system can amplify the risk of cardiovascular maladies

  2022cites this paper
• Fifteenth Annual Scientific Meeting-Institute Of Cardiovascular Science And Fifteenth Annual Scientific Meeting-Institute Of Cardiovascular Science And Medicine Medicine

  2022cites this paper
• Tumor Necrosis Factor-Related Apoptosis-Inducing Ligand (TRAIL) in Patients after Acute Stroke: Relation to Stroke Severity, Myocardial Injury, and Impact on Prognosis

  2022cites this paper
• Acute Decompensated Heart Failure in the Setting of Acute Coronary Syndrome.

  2022cites this paper
• Serial, Repeated, or Single Measurements of Natriuretic Peptides (BNP or NT‐proBNP) in Estimating Cardiovascular Risk: Is It the “Importance of Change Over Time” or “The Past Is Good, But the Present Is Better,” or Both, in Clinical Context?

  2022cites this paper
• Impact of socioeconomic and cardiovascular risk factors on the effect of genetic variants associated with NT-proBNP

  2022cites this paper
• THE IMPACT OF BIOMARKERS FOR THE DIAGNOSIS AND PROGNOSIS OF MYOCARDIAL INFARCTION

  2022cites this paper
• Optimal cut points of N-terminal of the prohormone brain natriuretic peptide (NT-proBNP) in patients with COVID-19

  2022cites this paper
• Inflammation and remodeling pathways and risk of cardiovascular events in patients with ischemic heart failure and reduced ejection fraction

  2022cites this paper
• Endogenous fibrinolysis inhibitors in acute coronary syndrome

  2021cites this paper
• NT-proBNP and Major Adverse Cardiovascular Events in Patients with ST-Segment Elevation Myocardial Infarction Who Received Primary Percutaneous Coronary Intervention: A Prospective Cohort Study

  2021cites this paper
• Thrombolysis In Myocardial Infarction (TIMI) Study Group: JACC Focus Seminar 2/8.

  2021cites this paper
• Eurasian clinical guidelines for the diagnosis and treatment of non-ST-segment elevation acute coronary syndrome (NSTE-ACS)

  2021cites this paper
• Improving 1-year mortality prediction in ACS patients using machine learning.

  2021cites this paper
• A Biomarker-Based Score for Risk of Hospitalization for Heart Failure in Patients With Diabetes

  2021cites this paper
• Risk Stratification of Patients with Acute Coronary Syndrome

  2021cites this paper
• Peripheral neutrophils and naive CD4 T cells predict the development of heart failure following acute myocardial infarction: A bioinformatic study.

  2021cites this paper
• Guía ESC 2020 sobre el diagnóstico y tratamiento del síndrome coronario agudo sin elevación del segmento ST

  2021cites this paper
• Impact of bedrest on cardiovascular events and complications associated with temporary pacemakers in patients waiting for permanent pacemaker implantation

  2021cites this paper
• B-type natriuretic peptide levels and its correlation with left ventricular functions and heart failure in patients of acute coronary syndromes

  2021cites this paper
• Biomarkers in the clinical management of patients with atrial fibrillation and heart failure

  2021cites this paper
• CMAR_A_305223 4699..4707

  2021cites this paper
• Predictive Value of Pro-BNP for Heart Failure Readmission after an Acute Coronary Syndrome

  2021cites this paper
• Natriuretic Peptides as Predictors of Cardiovascular Events and All-Cause Mortality.

  2021cites this paper
• Critical appraisal of the 2020 ESC guideline recommendations on diagnosis and risk assessment in patients with suspected non-ST-segment elevation acute coronary syndrome

  2021cites this paper
• Multi-modality biomarkers in the early prediction of ischaemic heart disease in middle-aged men during a 21-year follow-up

  2021cites this paper
• Predicting Survival for Patients with Malignant Pleural Effusion: Development of the CONCH Prognostic Model

  2021cites this paper
• SUPER LEARNER MODEL IN PREDICTION OF HEART ATTACK BASED ON CARDIAC BIOMARKERS

  2021cites this paper
• Serum NT-pro-BNP Levels Predict Cardiovascular Events in Acromegaly Patients

  2021cites this paper
• Cardiac Complications in Pregnancy: A Systematic Review and Meta-Analysis of Diagnostic Accuracy of BNP and N-Terminal Pro-BNP

  2021cites this paper
• Elevated FURIN levels in predicting mortality and cardiovascular events in patients with acute myocardial infarction.

  2020cites this paper
• Combined use of high-sensitivity ST2 and NT-proBNP for predicting major adverse cardiovascular events in coronary heart failure.

  2020cites this paper
• Assessment of Left Ventricular Functions in Hypertensive Diabetic Patients by Speckle Tracking Imaging: Correlation with Brain Natriuretic Peptide Levels

  2020cites this paper
• 2020 ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation.

  2020cites this paper
• Early changes in NT-proBNP levels predict new-onset heart failure in patients with STEMI.

  2020cites this paper
• Identification of Post-myocardial Infarction Blood Expression Signatures Using Multiple Feature Selection Strategies

  2020cites this paper
• Association of NT-proBNP and BNP With Future Clinical Outcomes in Patients With ESKD: A Systematic Review and Meta-analysis.

  2020cites this paper
• Myocardial infarction biomarker discovery with integrated gene expression, pathways and biological networks analysis.

  2020cites this paper
• Clinical impact of admission urinary 8-hydroxydeoxyguanosine level for predicting cardiovascular mortality in patients with acute coronary syndrome

  2020cites this paper
• The Biomarkers for Acute Myocardial Infarction and Heart Failure

  2020cites this paper
• The association of baseline N-terminal pro-B-type natriuretic peptide with short and long-term prognosis following percutaneous coronary intervention in non-ST segment elevation acute coronary syndrome with multivessel coronary artery disease: a retrospective cohort study

  2020influential citation
• Elevated B-Type Natriuretic Peptide Levels (BNP) with Association between Unstable Angina and Non-ST-Segment Myocardial Infarction patients

  2020cites this paper
• Relationship between baseline cardiac biomarkers and cardiovascular death or hospitalization for heart failure with and without sodium–glucose co‐transporter 2 inhibitor therapy in DECLARE‐TIMI 58

  2020cites this paper
• NT-proBNP level before primary PCI and risk of poor myocardial reperfusion: insight from the On-Time II trial.

  2020cites this paper
• Pro B-type Natriuretic Peptide and Midregional Proadrenomedullin are Associated with Incident Carotid Stenosis During Long Term Follow-up.

  2020cites this paper
• Cardiomyopathies and Arrhythmias Induced by Cancer Therapies

  2020cites this paper
• Number of Implanted Stents May Predict Posttraumatic Stress Disorder in Patients With Acute Myocardial Infarction

  2020cites this paper
• Statin Treatment of COVID-19

  2020cites this paper
• Brain Natriuretic Peptide for Predicting Contrast-Induced Acute Kidney Injury in Patients with Acute Coronary Syndrome Undergoing Coronary Angiography: A Systematic Review and Meta-Analysis

  2020cites this paper
• Clinical Implication of 'Obesity Paradox' in Elderly Patients With Acute Myocardial Infarction.

  2020cites this paper
• B-TYPE NATRIURETIC PEPTIDE(BNP) LEVELS AND ITS PROGNOSTIC VALUE IN ACUTE CORONARY SYNDROMES(ACS)

  2020cites this paper
• Higher incidence of acute respiratory distress syndrome in cardiac surgical patients with elevated serum procalcitonin concentration: a prospective cohort study

  2020cites this paper
• Beta Blockade in Patients after Acute Myocardial Infarction.

  2020cites this paper
• Plasma Renin Activity Is an Independent Prognosticator in Patients With Myocardial Infarction.

  2019cites this paper
• Elevated Level of Plasma B-Type Natriuretic Peptide (BNP) as a Prognostic Marker in Patients with Acute Coronary Syndrome

  2019cites this paper
• B-type natriuretic peptide trumps other prognostic markers in patients assessed for coronary disease

  2019cites this paper
• Cardiac Biomarkers in Acute Myocardial Infarction

  2019cites this paper
• Change of BNP between admission and discharge after ST-elevation myocardial infarction (Killip I) improves risk prediction of heart failure, death, and recurrent myocardial infarction compared to single isolated measurement in addition to the GRACE score

  2019cites this paper
• Identification of time-series differentially expressed genes and pathways associated with heart failure post-myocardial infarction using integrated bioinformatics analysis

  2019cites this paper
• Carbohydrate antigen 125 predicts pulmonary congestion in patients with ST-segment elevation myocardial infarction

  2019cites this paper
• B-type natriuretic peptide and its role in altering Ca2+-regulatory proteins in heart failure—mechanistic insights

  2019cites this paper
• Correlation of B-type natriuretic peptide with severity of coronary artery disease assessed by SYNTAX score ii in st elevation acute coronary syndrome patients

  2019influential citation
• Myocardial deformation imaging and prognostication in acute heart failure

  2019cites this paper
• Premorbid levels of high-sensitivity cardiac troponin T and natriuretic peptide and prognosis after incident myocardial infarction.

  2019cites this paper
• Different inflammatory profile in young and elderly STEMI patients undergoing primary percutaneous coronary intervention (PPCI): Its influence on no-reflow and mortality.

  2019cites this paper